HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Strategies aim to ensure cancer care for Americans ‘without financial ruin’ John DeRosier
• Would the addition of a public option to the US health care system bring down costs for patients?
• APPs have a growing role in the oncology workforce John Sweetenham, MD, FRCP, FACP
• Training essential to understand cancer risks, address barriers facing LGBTQ individuals Kelly Haviland, PhD, FNP-BC
• Link between ibrutinib-related hypertension, heart problems necessitates close monitoring Larry W. Buie, PharmD, BCOP, FASHP
• Addressing racism in medicine: Experts call on colleagues to turn talk into action Jennifer R. Southall
• ASH guidelines address ‘major gaps in our knowledge’ regarding sickle cell disease care Jennifer Byrne
• Uterine microbiome may explain racial disparity in endometrial cancer mortality Jennifer R. Southall
• Nivolumab plus chemotherapy prolongs PFS in gastric, gastroesophageal junction cancer Jennifer R. Southall
• Nivolumab may be ‘new standard’ in esophageal, gastroesophageal junction cancers Jennifer R. Southall
• Atezolizumab regimen fails to extend PFS in triple-negative breast cancer subset Jennifer R. Southall
• Addition of abemaciclib to endocrine therapy extends invasive DFS in breast cancer subset Jennifer R. Southall
• Amivantamab-lazertinib combination safe in EGFR-mutated NSCLC John DeRosier
• Lorlatinib ‘highly effective’ as first-line therapy for ALK-positive NSCLC Jennifer R. Southall
• Cemiplimab prolongs OS in NSCLC with high PD-L1 expression Mark Leiser
• Spartalizumab-based combination fails in BRAF-mutated advanced melanoma Alexandra (Sasha) Todak
• Pediatric protocol confers favorable outcomes for adolescents, young adults with ALL Mark Leiser
• Venetoclax regimen extends OS in AML subset Mark Leiser
• Pevonedistat plus azacitidine prolongs EFS in higher-risk myelodysplastic syndrome John DeRosier
• Antithymocyte globulin reduces acute GVHD incidence after matched sibling donor transplant John DeRosier
• Darolutamide shows ‘high efficacy’ for nonmetastatic prostate cancer Jennifer R. Southall
• Chemotherapy, surgery for gynecologic cancer not linked to higher COVID-19 mortality risk Jennifer R. Southall
• FDA approves Gavreto for lung cancer subset
• FDA approves immunotherapy regimen for advanced liver cancer
• FDA approves Bavencio for first-line maintenance of advanced bladder cancer
• American Society for Radiation Oncology members receive fellow designation
• Cancer geneticist to lead City of Hope’s Center for Precision Medicine
• Four institutions join Pediatric Brain Tumor Consortium